Insights On Pharmaceutical Production
-
2023 Pharmaceutical Manufacturing Trends
1/13/2023
Adaptability is the new superpower in pharma manufacturing. By staying on top of these trends, manufacturers will be better positioned for success in the competitive, rapidly evolving pharma industry.
-
Method Migration Of The USP Ibuprofen Assay And Organic Impurities Method
3/15/2023
An isocratic USP monograph for ibuprofen and related organic impurities was used to assess a method migration between HPLC systems. Explore results that demonstrate the ability to migrate methods.
-
A New Way To Perform mAb Capture
2/21/2024
Combining high-productivity chromatography methods and SU affinity membranes delivers a viable alternative to the current packed bed Protein A capture techniques for intensified purification of mAbs.
-
Small Molecule APIs: From Pre-RSM To Final API
8/31/2023
As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.
-
How Long Should Tablet Tooling Last?
7/5/2022
Learn how you can prolong and protect your investment by evaluating the life of punches and dies.
-
COGs Process Economics For Autologous Cell Therapy
8/11/2023
Analyze the cost distribution over time for autologous CAR T therapy manufacturing using process economics and additional insights. Discover how cell therapy manufacturers can combat these costs.
-
Transforming Analytics To Optimize Cell Line Development
8/30/2023
For cell line development, much of a workflow’s success hinges on how much analytical data a team can get – and how quickly – to inform their process.
-
Building Better Degraders: Targeted Protein Degradation Partners
3/1/2024
Learn from industry experts about the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and their role in constructing superior degrades.
-
Supply Chain Sustainability: Manufacturing Of RSMs And KSMs
10/3/2023
De-risking RSM and KSM procurement can be accomplished via several means, but local sourcing of raw materials and in-house production have proven tremendously effective.
-
De-Risking Drug Development With Organ-On-A-Chip Contract Research Services
3/25/2024
Delve into Emulate's variety of Organ-on-a-Chip services and tailored study design, supported by data-driven case studies showcasing its collaboration's impact on pharmaceutical decision-making.